Clinical Trial Update: A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of PF-08046049/SGN-BB228 in advanced melanoma and other solid tumors, with the conditions including cutaneo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms
• Cutaneous Melanoma
• Mesothelioma
• Non-small Cell Lung Cancer
• Pancreatic Neoplasms

Drugs mentioned

• PF-08046049 / SGN-BB228

Snippet

Sponsor: Seagen, a wholly owned subsidiary of Pfizer | Conditions: Cutaneous Melanoma, Non-small Cell Lung Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING